| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscapeCom...
Pfizer plans to sell its remaining BioNTech stake through a $508 million block trade, ending a profitable Covid-19 vaccine part...
https://www.bloomberg.com/news/articles/2025-11-13/pfizer-looks-to-sell-stake-in-pandemic-vaccine-partner-biontech
Novo Nordisk's Coramitug cut NT-proBNP levels and was well tolerated in a Phase 2 ATTR-CM trial, paving the way for its Pha...
Novo Nordisk shares are trading higher on Tuesday. The company recently lost its bidding war for Metsera Inc.
Cogent Biosciences stock rises as bezuclastinib plus Sutent shows 50% lower progression risk and strong efficacy in Phase 3 GIS...